Contribution of neuraminidase of influenza viruses to the sensitivity to serum inhibitors and reassortment efficiency

被引:0
|
作者
Kiseleva, I. V. [1 ]
Larionova, N. V. [1 ]
Bazhenova, E. A. [1 ]
Fedorova, E. A. [1 ]
Dubrovina, I. A. [1 ]
Isakova-Sivak, I. N. [1 ]
Rudenko, L. G. [1 ]
机构
[1] Russian Acad Med Sci, Dept Virol, Inst Expt Med, St Petersburg 197376, Russia
关键词
influenza virus; live attenuated influenza vaccine; neuraminidase; serum inhibitors; reassortment; NONSPECIFIC INHIBITORS; PHENOTYPIC FEATURES; IMMUNOGENICITY; HEMAGGLUTININ; EFFICACY; VACCINES; STRAINS;
D O I
10.3103/S0891416814030045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Live attenuated influenza vaccine (LAIV) consists of reassortant viruses with hemagglutinin (HA) and neuraminidase (NA) gene segments inherited from the circulating wild-type (WT) parental viruses and six internal protein-encoding gene segments from cold-adapted attenuated master donor viruses (genome composition 6 : 2). In this study, we describe the difficulties in development of LAIV strains depending on the phenotypic peculiarities of the WT viruses used for reassortment. Genomic-composition analysis of 849 reassortants revealed that over 80% of reassortants based on the inhibitor-resistant WT viruses inherited WT NA as compared to 26% of reassortants based on the inhibitor-sensitive WT viruses. In addition, the highest percentage of vaccine genotype reassortants was achieved when WT parental viruses were resistant to nonspecific serum inhibitors. We show that NA may play a role in the influenza virus' sensitivity to a nonspecific serum inhibitors. Replacing the NA of the inhibitor-sensitive WT virus with the NA of the inhibitor-resistant master donor virus significantly decreased the sensitivity of the resulting reassortant virus to nonspecific inhibitors.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 50 条
  • [41] Neuraminidase inhibitors for influenza complications
    Del Mar, Chris
    Doshi, Peter
    Hama, Rokuro
    Jones, Mark
    Jefferson, Tom
    Heneghan, Carl
    Onakpoya, Igho
    Howick, Jeremy
    LANCET, 2014, 384 (9950): : 1260 - 1261
  • [42] Safety of neuraminidase inhibitors for influenza
    Jones, Mark
    Del Mar, Chis
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (05) : 603 - 608
  • [43] GENETIC REASSORTMENT OF INFLUENZA-C VIRUSES IN MAN
    PENG, G
    HONGO, S
    MURAKI, Y
    SUGAWARA, K
    NISHIMURA, H
    KITAME, F
    NAKAMURA, K
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 3619 - 3622
  • [44] TreeKnit: Inferring ancestral reassortment graphs of influenza viruses
    Barrat-Charlaix, Pierre
    Vaughan, Timothy G.
    Neher, Richard A.
    PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (08)
  • [45] Bayesian inference of reassortment networks reveals fitness benefits of reassortment in human influenza viruses
    Mueller, Nicola F.
    Stolz, Ugne
    Dudas, Gytis
    Stadler, Tanja
    Vaughan, Timothy G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (29) : 17104 - 17111
  • [46] Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses
    Deyde, Varough M.
    Okomo-Adhiambo, Margaret
    Sheu, Tiffany G.
    Wallis, Teresa R.
    Fry, Alicia
    Dharan, Nila
    Klimov, Alexander I.
    Gubareva, Larisa V.
    ANTIVIRAL RESEARCH, 2009, 81 (01) : 16 - 24
  • [47] Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014
    Takashita, Emi
    Meijer, Adam
    Lackenby, Angie
    Gubareva, Larisa
    Rebelo-de-Andrade, Helena
    Besselaar, Terry
    Fry, Alicia
    Gregory, Vicky
    Leang, Sook-Kwan
    Huang, Weijuan
    Lo, Janice
    Pereyaslov, Dmitriy
    Siqueira, Marilda M.
    Wang, Dayan
    Mak, Gannon C.
    Zhang, Wenqing
    Daniels, Rod S.
    Hurt, Aeron C.
    Tashiro, Masato
    ANTIVIRAL RESEARCH, 2015, 117 : 27 - 38
  • [48] Evaluation of Neurmaminidase enzyme assays for susceptibility testing of Influenza viruses to Neuraminidase inhibitors.
    Wetherall, NT
    Zeller, J
    Hodges-Savola, C
    Zambon, M
    Hayden, F
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A76 - A76
  • [49] Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015
    Hurt, Aeron C.
    Besselaar, Terry G.
    Daniels, Rod S.
    Ermetal, Burcu
    Fry, Alicia
    Gubareva, Larisa
    Huang, Weijuan
    Lackenby, Angie
    Lee, Raphael T. C.
    Lo, Janice
    Maurer-Stroh, Sebastian
    Nguyen, Ha T.
    Pereyaslov, Dmitriy
    Rebelo-de-Andrade, Helena
    Siqueira, Marilda M.
    Takashita, Emi
    Tashiro, Masato
    Tilmanis, Danielle
    Wang, Dayan
    Zhang, Wenqing
    Meijer, Adam
    ANTIVIRAL RESEARCH, 2016, 132 : 178 - 185
  • [50] Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016
    Gubareva, Larisa V.
    Besselaar, Terry G.
    Daniels, Rod S.
    Fry, Alicia
    Gregory, Vicki
    Huang, Weijuan
    Hurt, Aeron C.
    Jorquera, Patricia A.
    Lackenby, Angie
    Leang, Sook-Kwan
    Lo, Janice
    Pereyaslov, Dmitriy
    Rebelo-de-Andrade, Helena
    Siqueira, Marilda M.
    Takashita, Emi
    Odagiri, Takato
    Wang, Dayan
    Zhang, Wenqing
    Meijer, Adam
    ANTIVIRAL RESEARCH, 2017, 146 : 12 - 20